Sign Up
Ready to replace complexity with clarity?
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
Automate Compliance TodayUS states A to Z: marijuana, THCA, delta-8, delta-9, delta-10, HHC
State-by-state mapMost read countries: marijuana, CBD and hemp status
All countries on the globeSubstances: status in every state for each one
Compare all substancesFederal hemp redefinition: P.L. 119-103, div. B, sec. 2019
Nov 12, 2026
Applies only to cannabinoids the plant cannot naturally produce.
Dec 11, 2026
The total-THC test, the 0.4 mg per container cap and the exclusion of converted cannabinoids start.
Latest regulatory actions, updated daily
All regulatory actionsHeadlines and the first four sentences are free. Full write-ups, impact reasoning and the archive are for members.
Member · $99/mo
Every rule change, the day it is made.
The price will rise. Join now and $99 a month stays your rate for life.
Become a memberOr read free: every action opens 30 days after it is published. Sign in with email
By topic
Licensing and permitsPackaging and labelingLab testing and QARetail complianceAdvertising and marketingBanking and paymentsTaxesShipping and logisticsTravel and transportLitigationSOPsFor your role
Regulators and agenciesBrands and operatorsRetailers and smoke shopsCultivatorsProcessorsLawyers and complianceInvestorsConsumers and travelersThe Regulator Brief · newsletter
Every rule change that matters, every Monday.
Free: the Monday brief, and every action 30 days after it is published.
Members: the paid weekly, daily alerts and every write-up.
Read by regulators, operators, lawyers and founders.
Cannabis lawyers
Licensed by state. Listings are not endorsements.
By state
Software and services
Compared by fit, never ranked.
Categories
For companies and firms
Be the listing operators and regulators find.
Software and services
Verified, $49/mo: domain-verified badge, your website link, a quote.
Featured, from $399/mo: labeled Featured in your category, monthly release notes.
Lawyers and firms
Claimed, $75/yr: Claimed badge and your firm's website link.
Featured, $199/mo: labeled Featured on your profile.
Claim your companyClaim a lawyer listingPlacements, flat monthly fee
State and country page sponsorshipsExclusive slot on a legality page and its postsRegulator Brief sponsorshipPresenting sponsor or mid-issue banner, free editionMember brief sponsor slotThe paid weekly, read by members onlyFeatured directory placementLabeled Featured in a software categoryCategory sponsorshipOwn one directory category across the sitePaid guest postsLabeled Paid guest post, sponsored linksWrite and partner
Pitch a paid guest postRead guest postsBecome an affiliateSend a tip or correctionContact the teamWho reads it
Regulators at federal, state and county agencies, plus the operators, lawyers and founders they regulate.
Get the media kitSee open placementsSubstances
US states, map and A to ZCountriesFederal hemp 2026: Nov 12 and Dec 11Compound index, every stateTravelling with cannabis or hempMembers get the daily alert email and every full write-up the morning it is published. Every action is free to read 30 days later.
For your role
All news and analysisGuidesAnalysisFAQsTemplates and SOPsCourt filing recapsNews by state and countrySoftware and services: Verified $49/mo, Featured from $399/mo. Lawyers and firms: Claimed $75/yr, Featured $199/mo. Listings are not endorsements.
Regulatory journalism, not legal advice. How we report
The landscape of hemp federal regulation changes is shifting in 2025, as Congress proposes major amendments targeting what many have labeled the "hemp loophole." With the explosive growth of hemp-derived cannabinoids—especially varieties like Delta-8 THC—legislators are seeking to tighten oversight and set new compliance standards for products that have rapidly flooded the market since the 2018 Farm Bill. This blog unpacks the current state of hemp regulations, analyzes Congressional actions underway, explores key compliance implications for businesses and consumers, and considers what a federal crackdown could mean for the industry's future.
Since the passage of the 2018 Farm Bill, which legalized hemp below 0.3% Delta-9 THC on a dry weight basis, the market for hemp-derived cannabinoids has flourished. Products containing compounds such as Delta-8, Delta-10, and various THCs and CBDs are now found in stores from coast to coast. However, legal ambiguities and a lack of comprehensive federal oversight have enabled a burgeoning market for intoxicating substances that many lawmakers argue were never intended to be legal under the Farm Bill's framework.
Now, Congress is poised to act. The House Committee on Appropriations, for example, has advanced proposals—most notably within the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (see H.R. 4121, 119th Cong.)—which, if enacted, would significantly restrict the production, distribution, and sale of hemp-derived intoxicants, including Delta-8 THC and its analogs.
The Farm Bill's intent was primarily to foster an agricultural market for industrial hemp and non-intoxicating cannabinoid products (like CBD). Instead, the legal distinction based solely on Delta-9 THC content unwittingly opened the door for manufacturers to chemically convert CBD into other, often intoxicating, forms of THC not expressly prohibited by federal law.
This regulatory gap—allowing psychoactive compounds to be sold with little federal scrutiny—has alarmed:
States such as Texas and Florida have already attempted their own bans and restrictions (source), but inconsistent patchwork laws and enforcement challenges have amplified the calls for strong federal action.
Major proposals include:
Legislative Status (as of September 2025):
Important: Current hemp businesses will likely face a transition period requiring them to:
As the FY 2026 Ag Appropriations Bill advances, the following deadlines are anticipated (but subject to change):
Federal and state agencies will likely step up:
The days of legal ambiguity for intoxicating hemp-derived cannabinoids are likely coming to a close. Businesses must proactively adapt to hemp federal regulation changes, stay alert to shifting compliance deadlines, and revise product lines and licensing strategies. Consumers should prepare for less marketplace variety but greater product safety and oversight.
For ongoing updates, compliance toolkits, and tailored industry support, turn to CannabisRegulations.ai—your partner for navigating the evolving federal hemp landscape and ensuring your operation remains compliant and successful.